Silex Systems Limited · ASX:SLX
Silex Systems — Shaw and Partners Uranium Conference 2023
19 slides from Silex Systems's conference presentation, Nov 2, 2023
Slide 1: Investor Presentation ASX cover announcement
Investor Presentation 2 November 2023 Silex Systems Limited (Silex) (ASX: SLX) (OTCQX: SILXY) is providing the attached presentation to support upcoming Investor Relations activities, including a presentation by Dr Michael Goldsworthy, Silex CEO to the Shaw and Partners Uranium Conference today. Mic
Slide 2: Silex Systems Limited Investor Presentation
Silex Systems Limited For personal use only Investor Presentation Shaw and Partners Uranium Conference (ASX: SLX) (OTCQX: SILXY) Dr Michael Goldsworthy CEO/Managing Director 2 November 2023 www.silex.com.au 1
Slide 3: Forward Looking Statements and Risk Factors
Forward Looking Statements and Risk Factors About Silex Systems Limited (ASX: SLX) (OTCQX: SILXY) Silex Systems Limited ABN 69 003 372 067 (Silex or Company) is a technology commercialisation company whose primary asset is the SILEX laser enrichment technology, originally developed at the Company’s
Slide 4: Our Mission: commercialise SILEX laser enrichment technology
Our Mission: to commercialise the unique SILEX laser enrichment technology for application to: For personal use only Uranium production and Silicon enrichment Medical isotope enrichment enrichment (silicon quantum computing) (new cancer therapies) (nuclear power) Our strategy is focused on extractin
Slide 5: Primary Focus on GLE Commercialisation
Primary Focus on GLE Commercialisation Uranium production and enrichment For personal use only (nuclear power) • SILEX uranium technology licencee Global Laser Enrichment (GLE) is progressing towards commercialisation • US-based GLE under JV ownership since 2021: 51% by Silex and 49% by Cameco Corpo
Slide 6: Nuclear Fuel Supply and Current Issues
Nuclear Fuel Supply and Current Issues The Nuclear Fuel Supply Chain For personal use only SILEX/GLE Opportunities Issues facing the Global Nuclear Fuel Supply Chain: - Western supply chain recent history - curtailments and under-investment in resources and production capability - Supply chain risks
Slide 7: US and EU Nuclear Fuel Requirements Supplied by Russia
US and EU Nuclear Fuel Requirements Supplied by Russia Russian Share of Global EU Nuclear Fuel US Nuclear Fuel Production Capacity1 Supplied by Russia2 Supplied by Russia1,3 Uranium (U308) ~14% ~20% ~14% For personal use only Conversion ~27% ~25% ~18% Enrichment (SWU) ~45% ~31% ~24% 1. WNA and UxC,
Slide 8: Recent Nuclear Fuel Market Price Trends
Recent Nuclear Fuel Market Price Trends For personal use only Source: UxC • Global nuclear fuel markets are pricing in the impact of a bifurcating market precipitated by looming Russian fuel sanctions/exclusions • According to UxC, the uranium spot price has increased by ~210% from ~US$24/lb (2019)
Slide 9: US Uranium and Enrichment Vulnerability
US Uranium and Enrichment Vulnerability US currently imports the vast majority of its nuclear fuel: - 95% of its uranium requirements (including ~14% from Russia) - 100% of its conversion requirements (including ~18% from Russia) For personal use only - 70% of its enriched uranium requirements (incl
Slide 10: Acceleration of GLE's CY2023 Activities for SILEX technology
Acceleration of GLE’s CY2023 Activities for SILEX technology GLE has unique potential to address the ‘Triple Opportunity’ that has emerged in the global nuclear fuel supply chain: • GLE joint venture owners Silex and Cameco agreed to a CY2023 plan and budget that accelerates activities in the commer
Slide 11: GLE's Potential Timelines for Commercialisation of SILEX technology
GLE’s Potential Timelines for Commercialisation of SILEX technology1 Baseline - GLE Commercialisation Timeline: PLEF Commercial Commercial Pilot Demonstration2 PLEF3 Feasibility and Licensing PLEF EPC4 Operations For personal use only c. 2025 c. 2027 c. 2030+ Accelerated - GLE Commercialisation Time
Slide 12: GLE's PLEF Production Plant Opportunity
GLE’s PLEF Production Plant Opportunity The PLEF Triple Opportunity Paducah Laser Enrichment Facility (PLEF) – an opportunity to deploy the SILEX technology in the US: • PLEF UF6 Production: Production of up to 5 million pounds (equivalent) natural grade uranium (as UF6) annually for up to 30 years
Slide 13: GLE's PLEF Multi-purpose Production Plant Opportunity
GLE’s PLEF Multi-purpose Production Plant Opportunity For personal use only Source: GLE, Multi-purpose PLEF (conceptual) www.silex.com.au 12
Slide 14: GLE's PLEF Production Plant Opportunities
GLE’s PLEF Production Plant Opportunities For personal use only * * GLE PLEF Process streams – NUF6 and LEU Production * DUF6: Depleted UF6 www.silex.com.au 13
Slide 15: PLEF UF6 Production Opportunity
PLEF UF6 Production Opportunity (Natural UF6 production from tails) Akin to a ‘Tier 1’ Accelerated Uranium Resource* Equivalent U3O8 For personal use only Commercial Based on low cost and Production Operation Date^ longevity of production Up to 5 million lbs p.a. for 2028 (Silex estimate of all-in c
Slide 16: GLE Value Proposition for Silex
GLE Value Proposition for Silex* 1) GLE Equity – Minimum 25%: • Silex currently holds 51% – Cameco has a call Option to acquire an additional 26% at fair market value • Option window opened 1 February 2023 – closes 30 months after successful TRL-6 demonstration For personal use only • Either way, Si
Slide 17: Significant Additional Opportunities
Significant Additional Opportunities For personal use only Silicon enrichment Medical isotope enrichment (silicon quantum computing) (new cancer therapies) • SILEX technology proven capable of producing highly enriched silicon • Newly commenced medical isotope project aiming to develop a process in
Slide 18: Summary
Summary GLE’s path to market is underpinned by the PLEF UF6 project for cost effective production of natural uranium (in the form of UF6) and significant value of the contained conversion component Acceleration of the pilot demonstration project - targeting completion in mid-2024 - which if successf
Slide 19: Thank you
For personal use only Thank you www.silex.com.au 18
Silex Systems — Shaw and Partners Uranium Conference 2023 on 6ix